AI tools for breast cancer detection fall short of radiologists' expectations

About half of 215 surveyed members of the Society of Breast Imaging already use FDA-approved AI tools for breast cancer detection, but the results fall short of expectations. Only 35 percent report lower recall rates, while 59 percent had expected them. The gap between promise and reality runs through every category measured.

Raccontata dathe-decoder.com